As Novo Nordisk transitions from the leadership of longtime CEO Lars Fruergaard Jørgensen to newly appointed chief Maziar ...

Drugmaker Novo Nordisk (NVO) will offer a reduced 2025 yearly bonus to its employees in Denmark due to the company’s lowered ...

Bagsværd, Denmark, 16 May 2025– Novo Nordisk today announced changes to its executive leadership and Board of Directors. As per mutual agreement with the Novo Nordisk Board, Lars Fruergaard ...

Danish drugmaker Novo Nordisk (NVO) has implemented a hiring freeze, which will apply across all markets and departments, ...

Maziar Mike Doustdar takes office as NVO's new CEO, bringing a proven global growth record to tackle rising obesity market ...

Novo Nordisk A/S (NVO) Q4 2018 Earnings Conference Call February 1, 2019 7:00 AM ET Company Participants Lars Fruergaard Jørgensen – Chief Executive Officer Karsten Munk Knudsen – Chief ...

Lars Fruergaard Jorgensen, incoming chief executive of Novo Nordisk, says the Danish drugmaker is “a very value-based company”, but when asked how he embodies the “Novo Nordisk Way ...

Lars Fruergaard Jorgensen Thank you all for listening in, and sorry for running a bit over time. We'll close our investor call now, and wish you all that you stay safe in these difficult times.

Lars Fruergaard Jørgensen says: "Serving as Novo Nordisk's CEO for the past eight years has been a privilege and an experience that I will always cherish. I am proud of the results I have helped ...